America’s Essential Hospitals Responds to 340B Rebate Proposal Approvals

FOR IMMEDIATE RELEASE

Statement attributable to:
Jennifer DeCubellis
President and CEO
America's Essential Hospitals

The Health Resources and Services Administration's approval of 340B rebate models for eight drugs is a clear case of the fox guarding the hen house. Drug manufacturers are the only winners under these rebate models, which will directly harm patients and the essential hospitals they depend upon for affordable, high-quality care.

Hospitals now have to manage a whole new set of administrative burdens, requiring more bureaucracy and more paperwork, with no benefit to patients' ability to access discounted drugs. We urge the administration to abandon these 340B rebate models and instead work to strengthen the 340B program.

# # #

About America's Essential Hospitals
America's Essential Hospitals is the leading association and champion for hospitals dedicated to high-quality care for all, including those who face social and financial barriers to care. Since 1981, America's Essential Hospitals has advanced policies and programs that promote health and access to health care. We support our more than 350 members with advocacy, policy development, research, education, and leadership development. Communities depend on essential hospitals for care across the continuum, health care workforce training, research, public health, and other services. Supported by Essential Hospitals Institute, the association's research and education arm, essential hospitals innovate and adapt to lead all of health care toward better outcomes and value.

Contact: James SwannDirector of [email protected]